Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F M Muggia

Showing results (131-140 of 317) with videos related to

Pageof 32
Sort By:
Advances in Pharmacology and Chemotherapy|January 1, 1978
Immune modulation and cancer controlS M Mikulski, M A Chirigos, F M Muggia
European Journal of Cancer & Clinical Oncology|February 1, 1984
Cardiotoxicity of anthracyclinesM D Green, J L Speyer, F M Muggia
Lancet (London, England)|January 10, 1976
Letter: Allergic reactions to cis platinumD D Von Hoff, M Slavik, F M Muggia
Cancer Treatment Reports|June 1, 1983
Kaposi's sarcoma: a new staging classificationR L Krigel, L J Laubenstein, F M Muggia
Cancer Treatment Reports|January 1, 1981
Future clinical investigations with anthracycline antibiotics in relation to daunorubicinF M Muggia, R H Blum, J C Wernz
Annals of Internal Medicine|August 1, 1976
5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemiaD D Von Hoff, M Slavik, F M Muggia
New York State Journal of Medicine|May 1, 1981
Lung cancer. Chemotherapy as curative treatmentL M Howard, R H Blum, F M Muggia
Frontiers of Gastrointestinal Research|January 1, 1979
Current adjuvant trials in colorectal cancerD L Kisner, H L Davis, F M Muggia
Cancer|November 1, 1974
Cell kinetic studies in patients with small cell carcinoma of the lungF M Muggia, S K Krezoski, H H Hansen
Cancer Treatment Reviews|June 1, 1979
The evaluation of cytotoxic drugsD D Von Hoff, M Rozencweig, F M Muggia
Pageof 32

Showing results (131-140 of 317) with videos related to

Sort By:
Pageof 32
Advances in Pharmacology and Chemotherapy|January 1, 1978
Immune modulation and cancer controlS M Mikulski, M A Chirigos, F M Muggia
European Journal of Cancer & Clinical Oncology|February 1, 1984
Cardiotoxicity of anthracyclinesM D Green, J L Speyer, F M Muggia
Lancet (London, England)|January 10, 1976
Letter: Allergic reactions to cis platinumD D Von Hoff, M Slavik, F M Muggia
Cancer Treatment Reports|June 1, 1983
Kaposi's sarcoma: a new staging classificationR L Krigel, L J Laubenstein, F M Muggia
Cancer Treatment Reports|January 1, 1981
Future clinical investigations with anthracycline antibiotics in relation to daunorubicinF M Muggia, R H Blum, J C Wernz
Annals of Internal Medicine|August 1, 1976
5-Azacytidine. A new anticancer drug with effectiveness in acute myelogenous leukemiaD D Von Hoff, M Slavik, F M Muggia
New York State Journal of Medicine|May 1, 1981
Lung cancer. Chemotherapy as curative treatmentL M Howard, R H Blum, F M Muggia
Frontiers of Gastrointestinal Research|January 1, 1979
Current adjuvant trials in colorectal cancerD L Kisner, H L Davis, F M Muggia
Cancer|November 1, 1974
Cell kinetic studies in patients with small cell carcinoma of the lungF M Muggia, S K Krezoski, H H Hansen
Cancer Treatment Reviews|June 1, 1979
The evaluation of cytotoxic drugsD D Von Hoff, M Rozencweig, F M Muggia
Pageof 32